This symposium equips healthcare professionals with the latest insights into emerging advances, established best practices, and ongoing challenges that shape both clinical outcomes and the patient and family experience for this unique population.

This annual conference brings together experts across disciplines to explore practical strategies for advancing health equity in underserved populations. This on-demand program is complimentary and available to all.

This course provides a comprehensive update on contemporary approaches to the diagnosis, management, and surveillance of disorders affecting the luminal gastrointestinal tract, liver, and pancreatobiliary system.

This clinical training focuses on integrating Reflectance Confocal Microscopy (RCM) and Ex Vivo Confocal Microscopy (EVCM) into practice, with insights into the latest advances in multimodal imaging and Artificial Intelligence (AI) in dermatology.

This conference focuses on the care of individuals living with serious illness and their caregivers, elevating and amplifying the art and science of hospice and palliative care worldwide.

This course offers a comprehensive review of thoracic pathology with clinical and radiologic correlations. The program features expert-led lectures, in-depth discussions, and case presentations on thoracic tumors, along with a multidisciplinary session dedicated to non-neoplastic lung diseases.

For more than a decade, Memorial Sloan Kettering Cancer Center has offered this annual course, delivering a comprehensive overview of essential topics at the intersection of critical care and oncology.

This on-demand activity provides deeper insights into the unique needs, challenges, and clinical considerations of pediatric critical care.

This on-demand program provides a state-of-the-art, interdisciplinary update on key topics related to the care of cancer patients with pulmonary comorbidities and complications arising from cancer and its treatments.

This on-demand program highlights recent advances in cancer treatment and toxicity management, including Radioligand Therapy, Antibody-Drug Conjugates, CAR T-cell Therapy, Bispecific Antibodies, Small Molecule Inhibitors, and Immune Checkpoint Inhibitors.